356 related articles for article (PubMed ID: 15316509)
21. Nasal challenge with allergen leads to maxillary sinus inflammation.
Baroody FM; Mucha SM; Detineo M; Naclerio RM
J Allergy Clin Immunol; 2008 May; 121(5):1126-1132.e7. PubMed ID: 18367240
[TBL] [Abstract][Full Text] [Related]
22. Effect of levocetirizine on nasal provocation testing with adenosine monophosphate compared with allergen challenge in allergic rhinitis.
Vaidyanathan S; Nair A; Barnes ML; Meldrum K; Lipworth BJ
Clin Exp Allergy; 2009 Mar; 39(3):409-16. PubMed ID: 19187327
[TBL] [Abstract][Full Text] [Related]
23. The effect of local hyperthermia on allergen-induced nasal congestion and mediator release.
Johnston SL; Price JN; Lau LC; Walls AF; Walters C; Feather IH; Holgate ST; Howarth PH
J Allergy Clin Immunol; 1993 Dec; 92(6):850-6. PubMed ID: 8258620
[TBL] [Abstract][Full Text] [Related]
24. Histamine release upon adenosine 5'-monophosphate (AMP) nasal provocation in allergic subjects.
Polosa R; Pagano C; Prosperini G; Low JL; Dokic D; Church MK; Crimi N
Thorax; 1999 Mar; 54(3):230-3. PubMed ID: 10325898
[TBL] [Abstract][Full Text] [Related]
25. A proof-of-concept study to assess the putative dose response to topical corticosteroid in persistent allergic rhinitis using adenosine monophosphate challenge.
Barnes ML; Menzies D; Nair AR; Hopkinson PJ; Lipworth BJ
Clin Exp Allergy; 2007 May; 37(5):696-703. PubMed ID: 17456217
[TBL] [Abstract][Full Text] [Related]
26. [Comparison of nasal histamine and allergen provocations in patients with allergic rhinitis].
Tahamiler R; Saritzali G; Canakçioğlu S
Kulak Burun Bogaz Ihtis Derg; 2007; 17(1):30-6. PubMed ID: 17483609
[TBL] [Abstract][Full Text] [Related]
27. Antiallergic actions of high topical doses of terbutaline in human nasal airways.
Svensson C; Greiff L; Andersson M; Alkner U; Grönneberg R; Persson CG
Allergy; 1995 Nov; 50(11):884-90. PubMed ID: 8748720
[TBL] [Abstract][Full Text] [Related]
28. [Tryptase determination in nasal washings in patients with allergic rhinitis].
Khreisat I; Simonetta A; Attinà EL; Monasterolo G; Bertone GF; Beccaria T; Rossi RE
Acta Otorhinolaryngol Ital; 1997 Feb; 17(1):22-5. PubMed ID: 9412151
[TBL] [Abstract][Full Text] [Related]
29. Nasal hyperosmolar challenge with a dry powder of mannitol in patients with allergic rhinitis. Evidence for epithelial cell involvement.
Koskela H; Di Sciascio MB; Anderson SD; Andersson M; Chan HK; Gadalla S; Katelaris C
Clin Exp Allergy; 2000 Nov; 30(11):1627-36. PubMed ID: 11069573
[TBL] [Abstract][Full Text] [Related]
30. Tryptase levels in nasal-lavage fluid as an indicator of the immediate allergic response.
Castells M; Schwartz LB
J Allergy Clin Immunol; 1988 Sep; 82(3 Pt 1):348-55. PubMed ID: 3049743
[TBL] [Abstract][Full Text] [Related]
31. Loratadine reduces allergen-induced mucosal output of alpha 2-macroglobulin and tryptase in allergic rhinitis.
Greiff L; Persson CG; Svensson C; Enander I; Andersson M
J Allergy Clin Immunol; 1995 Jul; 96(1):97-103. PubMed ID: 7542675
[TBL] [Abstract][Full Text] [Related]
32. Thresholds in nasal histamine challenge in patients with allergic rhinitis, patients with hyperreflectory rhinopathy, and healthy volunteers.
Wuestenberg EG; Hauswald B; Huettenbrink KB
Am J Rhinol; 2004; 18(6):371-5. PubMed ID: 15706984
[TBL] [Abstract][Full Text] [Related]
33. Physiologic responses and histamine release after nasal antigen challenge. Effect of atropine.
Baroody FM; Ford S; Lichtenstein LM; Kagey-Sobotka A; Naclerio RM
Am J Respir Crit Care Med; 1994 Jun; 149(6):1457-65. PubMed ID: 7516250
[TBL] [Abstract][Full Text] [Related]
34. Histamine and tryptase in nasal lavage fluid following challenge with methacholine and allergen.
Jacobi HH; Skov PS; Kampen GT; Poulsen LK; Reimert CM; Bindslev-Jensen C; Praetorius C; Malling HJ; Mygind N
Clin Exp Allergy; 1998 Jan; 28(1):83-91. PubMed ID: 9537785
[TBL] [Abstract][Full Text] [Related]
35. Serum tryptase in allergic rhinitis: effect of cetirizine and fluticasone propionate treatment.
Bruno G; Andreozzi P; Bracchitta S; Graf U; Santangelo G; Zaino S; Gaston N
Clin Ter; 2001; 152(5):299-303. PubMed ID: 11794849
[TBL] [Abstract][Full Text] [Related]
36. Seasonal non-allergic rhinitis (SNAR)--a new disease entity? A clinical and immunological comparison between SNAR, seasonal allergic rhinitis and persistent non-allergic rhinitis.
Wedbäck A; Enbom H; Eriksson NE; Movérare R; Malcus I
Rhinology; 2005 Jun; 43(2):86-92. PubMed ID: 16008061
[TBL] [Abstract][Full Text] [Related]
37. Activation of pulmonary mast cells by bronchoalveolar allergen challenge. In vivo release of histamine and tryptase in atopic subjects with and without asthma.
Wenzel SE; Fowler AA; Schwartz LB
Am Rev Respir Dis; 1988 May; 137(5):1002-8. PubMed ID: 2461667
[TBL] [Abstract][Full Text] [Related]
38. Mast cell inhibitor R112 is well tolerated and affects prostaglandin D2 but not other mediators, symptoms, or nasal volumes in a nasal challenge model of allergic rhinitis.
Guyer BJ; Shimamoto SR; Bradhurst AL; Grossbard EB; Dreskin SC; Nelson HS
Allergy Asthma Proc; 2006; 27(3):208-13. PubMed ID: 16913263
[TBL] [Abstract][Full Text] [Related]
39. Effects of intranasal corticosteroid on nasal adenosine monophosphate challenge in persistent allergic rhinitis.
Barnes ML; Biallosterski BT; Fujihara S; Gray RD; Fardon TC; Lipworth BJ
Allergy; 2006 Nov; 61(11):1319-25. PubMed ID: 17002709
[TBL] [Abstract][Full Text] [Related]
40. Effects of intranasal fluticasone and salmeterol on allergen-induced nasal responses.
Parameswaran K; Fanat A; O'Byrne PM
Allergy; 2006 Jun; 61(6):731-6. PubMed ID: 16677243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
